These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 3945256)

  • 1. Microvascular deposition of complement membrane attack complex in dermatomyositis.
    Kissel JT; Mendell JR; Rammohan KW
    N Engl J Med; 1986 Feb; 314(6):329-34. PubMed ID: 3945256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis.
    Kissel JT; Halterman RK; Rammohan KW; Mendell JR
    Arch Neurol; 1991 Jan; 48(1):26-30. PubMed ID: 1986724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular changes in early and advanced dermatomyositis: a quantitative study.
    Emslie-Smith AM; Engel AG
    Ann Neurol; 1990 Apr; 27(4):343-56. PubMed ID: 2353792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
    Basta M; Dalakas MC
    J Clin Invest; 1994 Nov; 94(5):1729-35. PubMed ID: 7962520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular alterations and the role of complement in dermatomyositis.
    Lahoria R; Selcen D; Engel AG
    Brain; 2016 Jul; 139(Pt 7):1891-903. PubMed ID: 27190020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.
    Schäfer H; Mathey D; Hugo F; Bhakdi S
    J Immunol; 1986 Sep; 137(6):1945-9. PubMed ID: 3528291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis.
    Gonçalves FG; Chimelli L; Sallum AM; Marie SK; Kiss MH; Ferriani VP
    J Rheumatol; 2002 Jun; 29(6):1301-7. PubMed ID: 12064850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin deposition in skeletal muscle in primary muscle diseases.
    Isenberg DA
    Q J Med; 1983; 52(207):297-310. PubMed ID: 6647747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5b-9 deposition in children with glomerular diseases.
    Nanulescu M; Rus HG; Niculescu F; Cristea A; Florescu P
    Med Interne; 1987; 25(2):99-104. PubMed ID: 3303285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
    Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
    Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H; Niculescu F; Cristea A; Vlaicu R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic transformation of SC5b-9 into an amphiphilic macromolecule resembling the C5b-9 membrane attack complex of complement.
    Bhakdi S; Bhakdi-Lehnen B; Tranum-Jensen J
    Immunology; 1979 Aug; 37(4):901-12. PubMed ID: 115783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrotizing myopathy with microvascular deposition of the complement membrane attack complex.
    De Bleecker J; Vervaet V; Van den Bergh P
    Clin Neuropathol; 2004; 23(2):76-9. PubMed ID: 15074581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane attack complex deposits in cutaneous lesions of dermatomyositis.
    Mascaró JM; Hausmann G; Herrero C; Grau JM; Cid MC; Palou J; Mascaró JM
    Arch Dermatol; 1995 Dec; 131(12):1386-92. PubMed ID: 7492126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.
    Biesecker G; Lavin L; Ziskind M; Koffler D
    N Engl J Med; 1982 Feb; 306(5):264-70. PubMed ID: 7054697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deposition of C5b-9 complexes and its precursors on E. coli J5 during complement activation enhances uptake and toxicities of gentamicin.
    Bloch EF; Morrison K; McDonald-Pinkett S; Baskin S; Campbell S; Peters S; Dillahunt S; Evans D; Lucas S; Macatangay A; Kanaan Y
    Immunol Invest; 2008; 37(3):245-61. PubMed ID: 18389443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL; Kolb WP; Sodetz JM
    J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
    Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
    J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy.
    Cybulsky AV; Quigg RJ; Salant DJ
    J Immunol; 1986 Sep; 137(5):1511-6. PubMed ID: 3745914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.